Nearly half of Parkinson’s disease patients surveyed in a Prague study reported symptomatic relief with cannabis use, Dr. Evzin Ruzicka told attendees of the seventh International Congress of Parkinson’s Disease and Movement Disorders here Tuesday.
“It’s difficult to directly study the medical effects of cannabis in the Czech Republic, where we conducted our research, because of its illegal status,” Dr. Ruzicka told Reuters Health. “Therefore, we had to conduct anonymous surveys.
To our knowledge, this is the first study to assess the effect of cannabis on Parkinson’s disease, and our findings suggest it may alleviate some symptoms.” Dr. Ruzicka is an attending neurologist at Charles University in Prague and is also a consultant at the Prague Movement Disorders Centre.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!